Commentary [Phase III clinical trial evaluating the use pazopanib in the treatment of kidney cancer - a discussion assumptions and results of the study] Commentary

Article Sidebar

PDF (Język Polski)


Published: Mar 30, 2012

Main Article Content

Kazimierz Drosik
Oddział Onkologii Klinicznej SP ZOZ Opolskie Centrum Onkologii im. prof. Tadeusza Koszarowskiego w Opolu

Abstract

None

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Article Details

How to Cite
1.
Drosik K. Commentary [Phase III clinical trial evaluating the use pazopanib in the treatment of kidney cancer - a discussion assumptions and results of the study]. OncoReview [Internet]. 2012Mar.30 [cited 2024May17];2(1(5):69-0. Available from: https://journalsmededu.pl/index.php/OncoReview/article/view/299
Issue
Vol 2 No 1(5) (2012)
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright: © Medical Education sp. z o.o. This is an Open Access article distributed under the terms of the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)